Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 106308-44-5 | Product Number: R0143
Rufinamide
Purity: >98.0%(HPLC)
- 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
| Size | Unit Price | Belgium | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|
| 25MG |
£16.00
|
Contact Us | 20 |
|
|
| 100MG |
£27.00
|
Ships within 1 week after ordering | 39 |
|
|
| 1G |
£171.00
|
1 | 15 |
|
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | R0143 |
Purity / Analysis Method
|
>98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__0H__8F__2N__4O = 238.20 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 106308-44-5 |
| Reaxys Registry Number | 13495800 |
| PubChem Substance ID | 253662493 |
| Merck Index (14) | 8293 |
| MDL Number | MFCD00865314 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Elemental analysis(Nitrogen) | 22.50 to 24.50 % |
| Melting point | 239.0 to 243.0 °C |
| NMR | confirm to structure |
| Melting Point | 241 °C |
| Solubility in water | Insoluble |
| Solubility (insoluble in) | Ethanol |
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H336 : May cause drowsiness or dizziness. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust. P271 : Use only outdoors or in a well-ventilated area. P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. P403 + P233 : Store in a well-ventilated place. Keep container tightly closed. P405 : Store locked up. |
| HS Number | 2933998090 |
References
- Rufinamide (a review)
- Rufinamide: a new anti-epileptic medication (a review)
- Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome (a review)
- Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions (a review)
- Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.